Clinical Trial Update: Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study evaluating interactions between rosuvastatin and lopinavir/ritonavir in HIV patients with hyperlipidemia; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Hyperlipidemia

Drugs mentioned

• Lopinavir/ritonavir (lopinavir/ritonavir)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Radboud University Medical Center | Conditions: HIV Infections, Hyperlipidemia | Phase 2 | Status: COMPLETED